Insulin glargine

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739 · see citing works

Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.

Pickup, J. C., KEEN, H., PARSONS, J. A., & Alberti, K. G. M. M. (1978) · BMJ · doi:10.1136/bmj.1.6107.204 · Cited by 563 · see citing works

Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor

Smith, L. E. H., Shen, W., Perruzzi, C. A., Söker, S., Kinose, F., Xu, X., Robinson, G. S., Driver, S., Bischoff, J. E., Zhang, B., et al. (1999) · Nature Medicine · doi:10.1038/70963 · Cited by 555 · see citing works

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.

Heinemann, L., Linkeschova, R., Rave, K., Hompesch, B., Sedlak, M., & Heise, T. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.644 · Cited by 474 · see citing works

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes

Ratner, R. E., Hirsch, I. B., Neifing, J. L., Garg, S. K., Mecca, T. E., & Wilson, C. A. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.639 · Cited by 455 · see citing works

Insulin analogues and their potential in the management of diabetes mellitus

Bolli, G. B., DiMarchi, R. D., Park, G. D., Pramming, S., & Koivisto, V. A. (1999) · Diabetologia · doi:10.1007/s001250051286 · Cited by 349 · see citing works

Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens

Jehle, P. M., Micheler, C., Jehle, D. R., Breitig, D., & Boehm, B. O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12459-5 · Cited by 185 · see citing works

Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor

Slieker, L. J., Brooke, G. S., DiMarchi, R. D., Flora, D. B., Green, L. K., Hoffmann, J. A., Long, H. B., Fan, L., Shields, J. E., Sundell, K. L., et al. (1997) · Diabetologia · doi:10.1007/s001250051402 · Cited by 138 · see citing works

The Long Acting Human Insulin Analog HOE 901: Characteristics of Insulin Signalling in Comparison to Asp(B10) and Regular Insulin

Berti, L., Kellerer, M., Bossenmaier, B., Seffer, E., Seipke, G., & Häring, H.-U. (1998) · Hormone and Metabolic Research · doi:10.1055/s-2007-978849 · Cited by 93 · see citing works

Diabetes: Current Perspectives

Betteridge, D. J. (1999) · Cited by 22 · see citing works

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

Atkinson, M. A., & Eisenbarth, G. S. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05415-0 · Cited by 1,491 · see citing works

Untitled work

Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479 · see citing works

The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline

Brown, R. J., Araújo‐Vilar, D., Cheung, P. T., Dunger, D. B., Garg, A., Jack, M., Mungai, L., Oral, E. A., Patni, N., Rother, K. I., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2466 · Cited by 532 · see citing works

ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus

(2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002960 · Cited by 481 · see citing works

The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin

Havelund, S., Plum, A., Ribel, U., Jonassen, I., Vølund, A., Markussen, J., & Kurtzhals, P. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036926.54824.37 · Cited by 431 · see citing works

Type 1 diabetes: recent developments

Devendra, D., Liu, E., & Eisenbarth, G. S. (2004) · BMJ · doi:10.1136/bmj.328.7442.750 · Cited by 352 · see citing works

Towards peakless, reproducible and long‐acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies

Heise, T., & Pieber, T. R. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00756.x · Cited by 240 · see citing works

Insulin structure and function

Mayer, J. P., Zhang, F. P. Y., & DiMarchi, R. D. (2007) · Biopolymers · doi:10.1002/bip.20734 · Cited by 235 · see citing works

Recombinant DNA Technology in the Treatment of Diabetes: Insulin Analogs

Vajó, Z., Fawcett, J., & Duckworth, W. C. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.5.0442 · Cited by 177 · see citing works

A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes

Hollander, P. A., Cooper, J., Bregnhøj, J. F., & Pedersen, C. B. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.11.001 · Cited by 161 · see citing works

Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews

Martis, R., Crowther, C. A., Shepherd, E., Alsweiler, J., Downie, M. R., & Brown, J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012327.pub2 · Cited by 159 · see citing works

Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy

Owen, A., & Rannard, S. P. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.003 · Cited by 159 · see citing works

Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime

Rossetti, P., Pampanelli, S., Fanelli, C. G., Porcellati, F., Costa, E., Torlone, E., Scionti, L., & Bolli, G. B. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1490 · Cited by 152 · see citing works

Insulin glargine: A systematic review of a long-acting insulin analogue

Wang, F., Carabino, J. M., & Vergara, C. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80156-x · Cited by 143 · see citing works

Insulin detemir: from concept to clinical experience

Home, P., & Kurtzhals, P. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.3.325 · Cited by 137 · see citing works

Perimacular retinal folds from childhood head trauma

Lantz, P., Sinal, S. H., Stanton, C. A., & Weaver, R. G. (2004) · BMJ · doi:10.1136/bmj.328.7442.754 · Cited by 131 · see citing works

Long-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 Diabetes

Pickup, J. C., & Renard, É. (2008) · Diabetes Care · doi:10.2337/dc08-s235 · Cited by 106 · see citing works

Basal insulin analogues in the management of diabetes mellitus: what progress have we made?

Owens, D. R., Matfin, G., & Monnier, L. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2469 · Cited by 102 · see citing works

Insulin Glargine

Dunn, C. J., Plosker, G. L., Keating, G. M., McKeage, K., & Scott, L. J. (2003) · Drugs · doi:10.2165/00003495-200363160-00007 · Cited by 95 · see citing works

Comparison of insulin detemir and insulin glargine in a basal—bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: A 52-week, multinational, randomized, open-label, parallel-group, Treat-to-Target noninferiority trial

Heller, S. R., Koenen, C., & Bode, B. W. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.10.006 · Cited by 94 · see citing works

Refining basal insulin therapy: what have we learned in the age of analogues?

DeVries, J. H., Nattrass, M., & Pieber, T. R. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.762 · Cited by 94 · see citing works

Evolution of Insulin: From Human to Analog

Tibaldi, J. M. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.07.005 · Cited by 88 · see citing works

Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews

Martis, R., Brown, J., Alsweiler, J. M., Downie, M. R., & Crowther, C. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012327 · Cited by 85 · see citing works

Insulin Therapy in Children and Adolescents with Type 1 Diabetes

Malik, F. S., & Taplin, C. E. (2014) · Pediatric Drugs · doi:10.1007/s40272-014-0064-6 · Cited by 84 · see citing works

Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir

Peterson, G. E. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x154178 · Cited by 81 · see citing works

Insulin Glargine

McKeage, K., & Goa, K. L. (2001) · Drugs · doi:10.2165/00003495-200161110-00007 · Cited by 78 · see citing works

Development of secreted proteins as biotherapeutic agents

Bonin-Debs, A. L., Boche, I., Gille, H., & Brinkmann, U. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.4.551 · Cited by 78 · see citing works

Insulin degludec: overview of a novel ultra long‐acting basal insulin

Gough, S. C. L., Harris, S. B., Woo, V. C., & Davies, M. J. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12052 · Cited by 74 · see citing works

New insulins in the treatment of diabetes mellitus

Lindholm, A. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0321 · Cited by 73 · see citing works

Recent advances in treatment of youth with Type 1 diabetes: better care through technology

Tamborlane, W. V., Bonfig, W., & Boland, E. A. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00626.x · Cited by 70 · see citing works

Timely initiation of basal insulin

Riddle, M. C. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.12.003 · Cited by 71 · see citing works

Insulin analogues: an example of applied medical science

Sheldon, B., Russell‐Jones, D., & Wright, J. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.01015.x · Cited by 69 · see citing works

Effects of Exercise on the Absorption of Insulin Glargine in Patients With Type 1 Diabetes

Peter, R., Luzio, S. D., Dunseath, G. J., Miles, A., Hare, B., Backx, K., Pauvaday, V., & Owens, D. R. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.560 · Cited by 66 · see citing works

Characterization and impact of peptide physicochemical properties on oral and subcutaneous delivery

Klepach, A., Tran, H., Mohammed, F. A., & ElSayed, M. E. H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114322 · Cited by 63 · see citing works

Survey of glargine use in 115 pregnant women with type 1 diabetes

Gallen, I. W., Jaap, A., Roland, J. M., & Chirayath, H. H. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02339.x · Cited by 60 · see citing works

Insulin and insulin analogs as antidiabetic therapy: A perspective from clinical trials

Kramer, C. K., Retnakaran, R. R., & Zinman, B. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.014 · Cited by 59 · see citing works

Use of Insulin Glargine During Pregnancy in a Type 1 Diabetic Woman

Devlin, J. T., Hothersall, L., & Jl, W. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1095-a · Cited by 55 · see citing works

A Century of Progress in Diabetes Care with Insulin: A History of Innovations and Foundation for the Future

Lee, S., & Yoon, K. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0163 · Cited by 53 · see citing works

Intentional Overdose with Insulin Glargine and Insulin Aspart

Tofade, T. S., & Liles, E. A. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.14.1412.43147 · Cited by 52 · see citing works

pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity

Kohn, W. D., Micanovic, R., Myers, S. L., Vick, A., Kahl, S. D., Zhang, L., Strifler, B. A., Li, S., Shang, J., Beals, J. M., et al. (2007) · Peptides · doi:10.1016/j.peptides.2007.01.012 · Cited by 53 · see citing works

Insulin Glargine: a review 8 years after its introduction

Goykhman, S., Drincic, A., Desmangles, J., & Rendell, M. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902775677 · Cited by 49 · see citing works

Pharmacology of Insulin Detemir

Kurtzhals, P. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(07)80004-1 · Cited by 50 · see citing works

Early hypoglycaemia after accidental intramuscular injection of insulin glargine

Karges, B., Boehm, B. O., & Karges, W. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01654.x · Cited by 46 · see citing works

Use of Insulin Glargine During Pregnancy in Seven Type 1 Diabetic Women

Woolderink, J. M., van Loon, A. J., Storms, F., de Heide, L., & Hoogenberg, K. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2594 · Cited by 46 · see citing works

Investigation of the Physico-Chemical Properties that Enable Co-Formulation of Basal Insulin Degludec with Fast-Acting Insulin Aspart

Havelund, S., Ribel, U., Hubálek, F., Høeg-Jensen, T., Wahlund, P., & Jonassen, I. (2015) · Pharmaceutical Research · doi:10.1007/s11095-014-1614-x · Cited by 45 · see citing works

Insulins: Past, Present, and Future

Borgoño, C. A., & Zinman, B. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.03.002 · Cited by 45 · see citing works

Insulin glargine in the treatment of type 1 and type 2 diabetes

Barnett, A. H. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.1.59 · Cited by 42 · see citing works

Therapeutic options for elderly diabetic subjects: open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs

Papa, G. F. S., Fedele, V., Chiavetta, A., Lorenti, I., Leotta, C., Luca, S., Rabuazzo, A. M., Piro, S., Alagona, C., Spadaro, L., et al. (2008) · Acta Diabetologica · doi:10.1007/s00592-007-0023-6 · Cited by 41 · see citing works

Use of Insulin Glargine During the First Weeks of Pregnancy in Five Type 1 Diabetic Women

Cianni, G. D., Volpe, L., Lencioni, C., Chatzianagnostou, K., Cuccuru, I., Ghio, A., Benzi, L., & Prato, S. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.982 · Cited by 41 · see citing works

Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus

Yki-J�rvinen, H. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.304 · Cited by 40 · see citing works

The endocrine pancreas and the control of blood glucose

Rang, H. P., Dale, M. M., Ritter, J., & Flower, R. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-06911-6.50031-1 · Cited by 38 · see citing works

Challenges in optimal metabolic control of diabetes

Liebl, A. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.286 · Cited by 37 · see citing works

Initiation of insulin glargine in children and adolescents with type 1 diabetes

Tan, C. Y., Wilson, D. M., & Buckingham, B. A. (2004) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2004.00039.x · Cited by 37 · see citing works

Expression of the multidrug resistance P-glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes.

Lepelley, P., Soenen, V., Preudhomme, C., Lai, J. L., Cosson, A., & Fenaux, P. (1994) · PubMed · Cited by 37 · see citing works

Pharmacokinetics and pharmacodynamics of insulin glargine 300 U/mL in the treatment of diabetes and their clinical relevance

Owens, D. R. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1202916 · Cited by 36 · see citing works

Defining the Role of Insulin Detemir in Basal Insulin Therapy

Morales, J. (2007) · Drugs · doi:10.2165/00003495-200767170-00007 · Cited by 36 · see citing works

An overview of insulin glargine

Home, P., & Ashwell, S. G. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.317 · Cited by 35 · see citing works

Key indices of glycaemic variability for application in diabetes clinical practice

Monnier, L., Bonnet, F., Colette, C., Renard, É., & Owens, D. R. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101488 · Cited by 34 · see citing works

Management of pregestational diabetes mellitus: a comparison of guidelines

Tsakiridis, I. G., Mamopoulos, A. M., Athanasiadis, A. P., Kourtis, A., & Dagklis, T. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1719481 · Cited by 35 · see citing works

Optimizing the Replacement of Basal Insulin in Type 1 Diabetes Mellitus: No Longer an Elusive Goal in the Post-NPH Era

Bolli, G. B., Andreoli, A. M., & Lucidi, P. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0039 · Cited by 33 · see citing works

Initiating and Intensifying Insulin Therapy in Type 2 Diabetes Mellitus

Tibaldi, J. M. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.03.023 · Cited by 32 · see citing works

Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation

Owens, D. R., Bailey, T. S., Fanelli, C. G., Yale, J., & Bolli, G. B. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.11.004 · Cited by 33 · see citing works

Effectiveness of continuous subcutaneous insulin infusion in hypoglycaemia-prone type 1 diabetes

Pickup, J. C., Kidd, J., Burmiston, S., & Yemane, N. (2005) · Practical Diabetes · doi:10.1002/pdi.732 · Cited by 31 · see citing works

Insulin treatment in diabetic pregnancy

Mathiesen, E. R., & Vaz, J. A. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.876 · Cited by 30 · see citing works

Verteporfin ocular photodynamic therapy

Bakri, S. J., & Kaiser, P. K. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.1.195 · Cited by 30 · see citing works

The Treat-to-Target Trial and Related Studies

Riddle, M. C. (2006) · Endocrine Practice · doi:10.4158/ep.12.s1.71 · Cited by 29 · see citing works

A Comprehensive Review of the Evolution of Insulin Development and Its Delivery Method

Sugumar, V., Ang, K. P., Al-Shanon, A. F., Sethi, G., Yong, P. V. C., Looi, C. Y., & Wong, W. F. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071406 · Cited by 29 · see citing works

INSULIN GLARGINE (LANTUS®)

Owens, & Griffiths, S. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11297.x · Cited by 38 · see citing works

New Developments in Insulin Therapy for Type 2 Diabetes

SORLI, C. H. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.07.006 · Cited by 31 · see citing works

Recent advances in the determination of insulins from biological fluids

Thomas, A., & Thevis, M. (2019) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.003 · Cited by 28 · see citing works

Insulin analogues and other developments in insulin therapy for diabetes

McAulay, V., & Frier, B. M. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.7.1141 · Cited by 28 · see citing works

Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes

Päivärinta, M., Tapanainen, P. J., & Veijola, R. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00341.x · Cited by 26 · see citing works

Polymer-Based Delivery of Peptide Drugs to Treat Diabetes: Normalizing Hyperglycemia and Preventing Diabetic Complications

Jeon, H., Lee, A.-J., & Ha, K. (2022) · BioChip Journal · doi:10.1007/s13206-022-00057-0 · Cited by 25 · see citing works

New Insulins and New Aspects in Insulin Delivery

Woo, V. C. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.04.006 · Cited by 25 · see citing works

The ongoing evolution of basal insulin therapy over 100 years and its promise for the future

Retnakaran, R. R., & Zinman, B. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14552 · Cited by 23 · see citing works

Degludec insulin: A novel basal insulin

Kalra, S., Unnikrishnan, A., Baruah, M. P., & Kalra, B. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.83056 · Cited by 23 · see citing works

Switching patients from insulin glargine-based basal-bolus regimens to a once daily insulin detemir-based basal-bolus regimen: results from a subgroup of the PREDICTIVE™ study

Yenigün, M., & Honka, M. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01973.x · Cited by 23 · see citing works

New Long-Acting Insulin Analogs: From Clamp Studies to Clinical Practice

Bolli, G. B., & DeVries, J. H. (2015) · Diabetes Care · doi:10.2337/dc14-2314 · Cited by 22 · see citing works

Safety of insulin glargine

Berger, M. (2000) · The Lancet · doi:10.1016/s0140-6736(05)72989-5 · Cited by 22 · see citing works

Study of the Aggregation of Insulin Glargine by Light Scattering

Coppolino, R., Coppolino, S., & Villari, V. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20609 · Cited by 21 · see citing works

Insulin Analogues in Children and Teens with Type 1 Diabetes: Advantages and Caveats

Rachmiel, M., Perlman, K., & Daneman, D. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2005.07.010 · Cited by 20 · see citing works

A evolução da insulinoterapia no diabetes melito tipo 1

Pires, A. C., & Chacra, A. R. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000200014 · Cited by 21 · see citing works

A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus

Candido, R., Wyne, K. L., & Romoli, E. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0422-4 · Cited by 21 · see citing works

Experience with Insulin Analogues in Children

Danne, T., Deiss, D., Hopfenmüller, W., von Schütz, W., & Kordonouri, O. (2002) · Hormone Research in Paediatrics · doi:10.1159/000053312 · Cited by 20 · see citing works

One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs

Bolli, G. B., Porcellati, F., Lucidi, P., Fanelli, C. G., & Owens, D. R. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154935 · Cited by 18 · see citing works

Insulin glargine and its place in the treatment of Types 1 and 2 diabetes mellitus

Chatterjee, S., Tringham, J. R., & Davies, M. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.10.1357 · Cited by 19 · see citing works

Current management of gestational diabetes mellitus

Menato, G., Bo, S., Signorile, A., Gallo, M., Cotrino, I., Poala, C. B., & Massobrio, M. (2007) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.3.1.73 · Cited by 19 · see citing works

Insulin analogues: have they changed insulin treatment and improved glycaemic control?

Madsbad, S. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.206 · Cited by 19 · see citing works

Insulin detemir: A historical perspective on a modern basal insulin analogue

Meneghini, L., Liebl, A., & Abrahamson, M. J. (2010) · Primary care diabetes · doi:10.1016/s1751-9918(10)60007-1 · Cited by 17 · see citing works

Analysis of oligomeric stability of insulin analogs using hydrogen/deuterium exchange mass spectrometry

Nakazawa, S., Hashii, N., Harazono, A., & Kawasaki, N. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.09.002 · Cited by 18 · see citing works

Glargine safety, diabetes and cancer

Rendell, M., Aktürk, H. K., & Tella, S. H. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.770469 · Cited by 18 · see citing works

Pharmacologic modifications of hormones to improve their therapeutic potential for diabetes management

Garber, A. J. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00457.x · Cited by 15 · see citing works

Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 Diabetes

Schiavon, M., VISENTIN, R., Giegerich, C., Klabunde, T., Cobelli, C., & Man, C. D. (2019) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2019.2919250 · Cited by 15 · see citing works

The Association of Insulin Medication Possession Ratio, Use of Insulin Glargine, and Health Benefit Costs in Employees and Spouses With Type 2 Diabetes

Kleinman, N. L., Schaneman, J. L., & Lynch, W. D. (2008) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e3181875e9b · Cited by 15 · see citing works

Paediatric diabetes: achieving practical, effective insulin therapy in type 1 and type 2 diabetes

Danne, T., & BECKER, D. J. (2007) · Acta Paediatrica · doi:10.1111/j.1651-2227.2007.00494.x · Cited by 15 · see citing works

A Brief Atlas of Insulin

Ayan, E. B., & DeMi̇rci̇, H. (2022) · Current Diabetes Reviews · doi:10.2174/1573399819666220610150342 · Cited by 14 · see citing works

Insights in Regulated Bioanalysis of Human Insulin and Insulin Analogs by Immunoanalytical Methods

Bowsher, R. R., & Nowatzke, W. L. (2011) · Bioanalysis · doi:10.4155/bio.11.50 · Cited by 14 · see citing works

Insulin Glargine Use During Pregnancy

Pantalone, K. M., Faiman, C., & Olansky, L. (2011) · Endocrine Practice · doi:10.4158/ep11083.ra · Cited by 13 · see citing works

Insulin glargine: a new basal insulin analogue

Younis, N. (2002) · QJM · doi:10.1093/qjmed/95.11.757 · Cited by 13 · see citing works

Insulin detemir, does a new century bring a better basal insulin?

Hordern, S. V. M., & Russell-Jones, D. L. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00544.x · Cited by 13 · see citing works

Insulin glargine (Aventis Pharma).

Jones, R. (2000) · PubMed · Cited by 1 · see citing works

Insulin glargine (Lantus), a new long-acting insulin.

(2001) · PubMed

Use of a New Long-Acting Insulin in Type 1 Diabetes

Brett, A. (2000) · Journal watch · doi:10.1056/jw200012050000004

Insulin Glargine: a review 8 years after its introduction

Goykhman, S., Drincic, A., Desmangles, J., & Rendell, M. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902775677 · Cited by 49 · see citing works

Glargine (Lantus): A new horizon ultralong basal insulin in type II diabetes along with triple drug

Premanidhi, P. (2015) · Journal of Diabetes & Metabolism